Immatics N.V. — Form SCHEDULE 13D/A
Filed August 27, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
Perceptive Advisors LLC filed an amended Schedule 13D/A on August 27, 2026, regarding beneficial ownership in Immatics N.V., a biologics company (SIC 2836). The filing document itself contains no substantive disclosure of ownership percentages, share counts, acquisition details, or dollar amounts—only metadata showing the filer's address (New York) and the subject company's address (Tübingen, Germany). The specific amendment details are not visible in the provided text excerpt.
Why this rating
Amendment of existing Schedule 13D is routine disclosure. No material transaction, stake change, or business event disclosed in visible text; likely administrative update or clarification.
See more from August 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.